The Nasdaq 100 closed slightly higher on Monday, with investors keeping an eye on some interesting insider trades. Insider sales can indicate various things, such as preplanned sales or concerns about the company’s prospects. However, they should not be the sole basis for investment decisions.
Let’s take a look at a few recent notable insider sales. For more information, you can visit Benzinga’s insider transactions platform.
Amazon.com:
– Senior Vice President David Zapolsky sold a total of 42,816 shares of Amazon.com, Inc. (AMZN) at an average price of $145.13, receiving around $6.21 million from the sale.
– Wedbush reiterated Amazon.com with an Outperform rating and maintained a $180 price target.
– Amazon is a leading online retailer and one of the highest-grossing e-commerce aggregators, generating $386 billion in net sales and approximately $578 billion in estimated physical/digital online gross merchandise volume in 2021.
Electronic Arts:
– Chief Legal Officer Jacob J Schatz sold 1,000 shares of Electronic Arts Inc. (EA) at an average price of $122.34, receiving around $122,340 from the sale.
– Video game director Stig Asmussen, known for his role in reviving Electronic Arts’ Star Wars game franchise, is bidding farewell to the company.
– EA is one of the world’s largest third-party video game publishers and has transitioned from a console-based video game publisher to one of the largest publishers on consoles, PC, and mobile.
Pinterest:
– Chief People Officer Christine Deputy sold a total of 45,153 shares of Pinterest, Inc. (PINS) at an average price of $26.48, receiving around $1.2 million from the sale.
– Pinterest reported a revenue beat for the second quarter.
– Pinterest is an online product and idea discovery platform that helps users gather ideas on various topics.
Moderna:
– President Stephen Hoge sold 15,000 shares of Moderna, Inc. (MRNA) at an average price of $112.99, receiving around $1.69 million from the sale.
– The EMA Committee for Medicinal Products for Human Use recommended authorization of Moderna’s updated COVID-19 vaccine in the EU.
– Moderna is a commercial-stage biotech company known for its mRNA technology, which was validated with its COVID-19 vaccine.
For more news and updates, you can check out Benzinga’s premarket coverage. Remember, this article is for informational purposes only and does not provide investment advice.